Avexitide, which has been granted FDA breakthrough therapy designation, has shown significant effectiveness in treating Postbariatric Hypoglycemia (PBH) and congenital hyperinsulinism, and is expected to commence Phase 3 trials for PBH by early 2025
But I was never able to lose weight, and that was really frustrating for me. Serena recalls a trip to Paris, in particular, during which she routinely walked 20,000 to 30,000 steps per daypartially because she loves strolling Paris (who doesnt!?) and partially because she was trying to get fit
For something more lasting, consider rewarding yourself with a piece of jewelry, a tech gadget, or a subscription to a streaming or audiobook service
Nature 542 (7640), 177185
In skincare, it earns its keep as a calming and repairing ingredient
This medication mimics a hormone, called GLP-1, that naturally occurs in our body